The U937 monocytic cell line was used to determine whether antibodies could facilitate infection and replication of the arenaviruses, Pichinde virus (PV) and Lassa fever virus (LFV). When high dilutions of PV-immune serum were added to cultures simultaneously with PV inoculum, virus replication was dramatically (1000-fold) increased. Low dilutions of this antiserum neutralized the virus. LFV also replicated in U937 cells. The presence of LFV-specific immune serum in the growth medium increased the viral titre as much as 10000-fold. Addition of heat-aggregated IgG partially inhibited antibody-mediated enhancement, probably by inhibiting the binding of immune complexes to the monocytic cells.
Incubation time.
albigularis, passaged once through hamster brain and then repeatedly through strain 13 guineapig spleens (Jahrling et al., 1981) . LFV was the reference Josiah strain initially isolated from a patient and subsequently passaged four times in Vero cells. PV antiserum was obtained from a rhesus monkey inoculated with virus. The monkey demonstrated no illness but developed an 80 % plaque reduction neutralization titre (PRN80) of 1:128. LFV antiserum was obtained from a rhesus monkey inoculated with LFV. This monkey recovered from a Lassa fever-like illness and developed a PRN80 titre of 1:200. Both antisera were used at a final dilution of 1:5000. For infectivity studies U937 cells were washed and pelleted in 50 ml conical tubes at 1600 g for 15 min at 23 °C. Antiserum (or normal monkey serum) and virus were diluted in cell medium, and 100 ~tl of each was added to the cell pellet. Cells, virus and antiserum were incubated at 37 °C for 60 min, washed twice in medium and resuspended in 1.5 ml at a cell concentration of 5 × 105/ml before addition to individual wells of six-well tissue culture plates. Antiserum or normal serum was again added to a final dilution of 1 : 5000. Cultures were maintained at 37 °C in air containing 5 % CO2. Samples were removed at various times and infectious virus was measured as p.f.u, on Vero cell monolayers. Samples for assay were serially diluted and added to cells, after which virus was allowed to adsorb for 60 min at 37 °C. Monolayers were overlaid with 1% agarose containing Eagle's basal medium supplemented with Earle's salts and HEPES buffer. They were incubated at 37 °C in humidified air containing 5% CO2 for 5 days (4 days when assaying for LFV p.f.u.). At this time, 2 ml of Puck's saline A containing 1:6000 neutral red was added to the cultures. Plaques were counted after an additional incubation of 18 to 24 h. PRN80 titres were determined by both the constant serum-virus dilution method and the serum dilution, plaque reduction method (Jahrling, 1983) .
To determine whether immune serum would increase the production of PV in U937 cells, PVimmune serum and two concentrations of virus inoculum were added to U937 cells and the cultures were incubated and then washed to remove residual virus. The cells were resuspended in medium containing antiserum and samples were removed for virus titration after incubation at 48, 72 and 96 h (experiment 1, Table 1 ). After 48 h, cultures inoculated with an m.o.i, of 1 to which normal serum had been added contained no infectious virus while antiserum-treated cultures had supernatant titres greater than 102"5. The increase in virus titre in the presence of specific antiserum was noted at multiplicities of 1 and 0.1 and at all sampling times.
To test the possibility that increased virus production was mediated by the binding of viral immune complexes to cellular Fc receptors, heat-aggregated IgG was used to block immune complex binding (experiment 2, Table 1 ). Cultures containing antiserum again showed significantly higher virus titres but addition of the IgG reduced virus titres when measured at 48 and 96 h. 1 shows that U937 cells were infected in the presence of various dilutions of PV antiserum. Serum dilutions were added to a constant number of U937 cells and virus. At the 1:10 antiserum dilution, the viral titre was less in those cultures containing normal serum, suggesting neutralization. At higher dilutions, the virus titre increased and remained at about 104.
The possibility of antibody-enhanced infectivity of LFV was also tested. As shown in Fig. 2 , U937 cells were capable of supporting virus replication. In the presence of antiserum, the growth of virus was dramatically increased, resulting in titres of virus increased by as much as 10000-fold.
In these studies, monkey antiserum against PV markedly increased viral replication in U937 cells and heat-aggregated IgG inhibited the antibody-induced increase. Other studies of antibody enhancement in U937 cells have implicated Fc receptors in the mechanism of enhancement: only Fc receptor-bearing cells showed enhancement (Unkeless et al., 1975) ; F(ab')2 did not mediate increases in viral titre, and monoclonal antibody to Fc receptors blocked the antibody-induced increase (Peiris et al., 1981) .
Some enhancement studies have characterized individual sera for both the ability to neutralize virus at one concentration and to enhance infectivity at another lower concentration (King et aL, 1984; Hotta et al., 1984; Peiris et al., 1982; Peiris & Porterfield, 1979; Brandt et al., 1982) . Replication of PV in U937 cells was diminished at high antiserum concentrations. At low antiserum concentrations, virus titres were significantly increased. This effect might have been the result of dilution of populations of neutralizing antibodies beyond their effectiveness with unmasking of populations of enhancing antibodies. Alternatively, the concentration of a single antibody population, with both neutralizing and enhancing properties, might have been the determining factor. Studies using monoclonal antibodies (MAbs) against West Nile virus showed that one of three MAbs could both neutralize virus and enhance infectivity (Peiris et al., 1982) . Studies in rico have corroborated the evidence in vitro for antibody enhancement of virus replication for a number of viruses. Passive immunization of rhesus monkeys with dengue antiserum resulted in increased virus titres in transfused animals (Halstead, 1979) . Mice injected simultaneously with MAb and yellow fever virus exhibited a decrease in mean time to death which was dependent on the virus strain, the particular antibody and its concentration (Barrett & Gould, 1986) . In contrast, studies using antiserum to treat monkeys and guinea-pigs infected with LFV have shown a beneficial effect, with no antibody-associated increase in viraemia or decrease in survival time in either species (Jahrling, 1983; Jahrling & Peters, 1984) .
The present studies clearly demonstrate antibody-mediated enhancement of virus infection of U937 cells for two arenaviruses, PV and LFV. These studies tested only a single PV antiserum and a single LFV antiserum, but comparisons between sera of different titres and differences in strain specificity might help to define this phenomenon further. As with other viral infections in which immune enhancement has been demonstrated, the implications for human disease are uncertain.
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